Health Affairs

Supreme Court Endorses Broad Government View Of ERISA ‘Church Plan’ Definition

On June 5, 2017, the Supreme Court released Advocate Health Care Network v. Stapleton , unanimously (with Justice Gorsuch not yet participating) accepting the federal government’s interpretation of the Employee Retirement Income Security Act’s (ERISA...

Published Tue, Jun 06 2017 1:31 PM by Health Affairs BlogHealth Affairs Blog

Filed under: Following the ACA, ERISA

Investing In Policy And Advocacy: A Foundation Shares Lessons Learned

Working on advocacy and policy is challenging. Not only is it complex, fluid, and increasingly politicized, it is also challenging to measure progress and communicate success. Some Background Understanding this, in 2012, the Foundation for a Healthy Kentucky...

Published Tue, Jun 06 2017 9:54 AM by Health Affairs BlogHealth Affairs Blog

Filed under: Health Reform, Policy, Politics, Insurance, States, Coverage, Medicaid, Health Law, Health Philanthropy, GrantWatch, Insurance and Coverage, Medicaid and CHIP, Matt Bevin, Kentucky

The Tower Of Babel In Clinical Research: PCORnet’s Common Data Model Cracks The Foundation

Across all medical specialties, there is a severe lack of high-quality clinical evidence, in part because the gold standard for evidence is large-scale randomized controlled clinical trials. Such trials are on an unsustainable cost trajectory, as they...

Published Tue, Jun 06 2017 9:00 AM by Health Affairs BlogHealth Affairs Blog

Filed under: Big Data, Innovations in Care Delivery, Costs and Spending, PCORI, PCORnet, clinical trials, clinical research, Drugs and Medical Innovation, Common Data Model

The CBO’s Updated Estimate Of The AHCA

On May 24, the Congressional Budget Office (CBO) released its assessment of the American Health Care Act (AHCA) . The estimate reflects the impact of two amendments that were key to the US House of Representatives’ passage of the bill three weeks earlier...

Published Tue, Jun 06 2017 4:47 AM by Health Affairs BlogHealth Affairs Blog

Filed under: Following the ACA, Insurance and Coverage, Costs and Spending, Medicaid and CHIP, Congressional Budget Office, American Health Care Act

Health Affairs’ June Issue: Pursuing Health Equity

The June issue of Health Affairs , a theme issue, explores the pursuit of health equity and the obligations of the health care sector to achieve it. The issue examines the subject from two perspectives: equity in care, and the relationship between social...

Published Mon, Jun 05 2017 1:03 PM by Health Affairs BlogHealth Affairs Blog

Filed under: Elsewhere@ Health Affairs, Health Affairs journal

This Intervention Helps Underserved Women Access Needed Postpartum Care

Pregnancy and childbirth can exacerbate many health risks, especially among underserved women or those who have a hard time getting health care. Diabetes, hypertension, and depression are all serious health conditions that occur frequently during pregnancy...

Published Mon, Jun 05 2017 8:28 AM by Health Affairs BlogHealth Affairs Blog

Filed under: Primary Care, Quality, Payment Policy, Medicaid and CHIP, health equity, Women's Health, Maternal Health, maternal depression, postpartum care

The Senate Should Build Automatic Enrollment Into Health Reform. Here’s How.

As the discussion over the future of health reform continues in the United States Senate, some Republicans are looking for ways to boost coverage levels, help stabilize insurance markets, and lower health costs. For years, the U.S. has had insurance enrollment...

Published Mon, Jun 05 2017 7:29 AM by Health Affairs BlogHealth Affairs Blog

Filed under: Following the ACA, Insurance and Coverage, high deductible health plans, auto-enrollment, ACA repeal and replace, AHCA

On Objections To Contraceptive Coverage, Trump Administration Appears Set To Reverse Obama Approach

On May 30, 2017, a draft of an interim final rule promulgated by the Departments of Health and Human Services, Labor, and Treasury, addressing conscience-based objections to the coverage of contraceptives under the preventive services requirement of the...

Published Fri, Jun 02 2017 10:11 AM by Health Affairs BlogHealth Affairs Blog

Filed under: Following the ACA, Insurance and Coverage, Women's Health, contraceptive coverage, Preventive Services Mandate, HRSA, ERISA

ERISA: A Bipartisan Problem For The ACA And The AHCA

The Supreme Court has once again been called on to mediate the boundaries of a far-reaching, infamously complex, federal employee benefits law. And once again this law may have an important and unanticipated effect on health care. The main goal of this...

Published Fri, Jun 02 2017 8:38 AM by Health Affairs BlogHealth Affairs Blog

Filed under: States, Following the ACA, Insurance and Coverage, All-Payer Claims Database, SCOTUS, Essential Health Benefits, church plans, Gobeille v. Liberty Mutual Insurance Co., ERISA, Zubik v. Burwell, AHCA, Advocate Health Care Network v. Stapleton

Debunking The Pharmaceutical Research ‘Free Rider’ Myth: A response To Yu, Helms, And Bach

Policy researchers at the Memorial Sloan Kettering Center for Health Policy and Outcomes have published a recent, valuable Health Affairs Blog post . The post shows that major pharmaceutical companies that manufacture some of the top-selling drugs “charge...

Published Fri, Jun 02 2017 7:41 AM by Health Affairs BlogHealth Affairs Blog

Filed under: Payment Policy, Costs and Spending, Research and Development, Big Pharma, drug pricing, drug innovation, Drugs and Medical Innovation, free-rider myth

Drug Prices And Medical Innovation: A Response To Yu, Helms, and Bach

In a recent Health Affairs Blog post, Nancy Yu, Zachary Helms, and Peter Bach note that prices for top-selling drugs are higher in the United States than in other countries. They conclude that “premium pricing [in the United States] exceeds what is needed...

Published Fri, Jun 02 2017 7:27 AM by Health Affairs BlogHealth Affairs Blog

Filed under: Costs and Spending, Research and Development, Big Pharma, drug pricing, drug innovation, Drugs and Medical Innovation

ACA Round-Up: Litigation Over Cost-Sharing Reductions And Reinsurance Fees, Tax Filings, And More

On May 30 the House of Representatives filed its response to the motion of attorneys general from 15 states and the District of Columbia asking that the stay in House v. Price be lifted and that they be allowed to intervene in the appeal. The federal...

Published Thu, Jun 01 2017 2:09 PM by Health Affairs BlogHealth Affairs Blog

Filed under: Following the ACA, Insurance and Coverage, risk corridor payments, house v. price

What Evidence Is Needed To Transform Health And Health Care?

While there is consensus that more reform is needed to improve value in the US health care system, there is less agreement on the mechanisms for achieving that broad aim. Put simply, while many agree on the what, they do not agree on the how. Efforts...

Published Thu, Jun 01 2017 10:30 AM by Health Affairs BlogHealth Affairs Blog

Filed under: Health Reform, Consumers, Insurance, Health Care Costs, Coverage, Medicaid, Health Law, Health Philanthropy, GrantWatch, Insurance and Coverage, Medicaid and CHIP, evidence, Affordable Care Act, health policy research, Robert Wood Johnson Foundation, American Health Care Act

For Patients With Multiple Chronic Conditions, Improving Care Will Be A Bipartisan Effort

Editor’s Note: This is the third in a five-part Health Affairs Blog series, produced in conjunction with the Bipartisan Policy Center, examining current issues and care models in the delivery system reform effort. Each post will be jointly authored by...

Published Thu, Jun 01 2017 9:04 AM by Health Affairs BlogHealth Affairs Blog

Filed under: Chronic Care, Medicare, Social Determinants of Health, Payment Policy, Insurance and Coverage, Costs and Spending, Medicaid and CHIP, Long-term Services and Supports, Alternative Payment Models, Bipartisan Policy Center, bipartisan delivery system reform, integrated models of care, CHRONIC Care Act

Pharmaceutical Product Hopping: A Proposed Framework For Antitrust Analysis

Skyrocketing drug prices are in the news. Overnight price increases have riveted the attention of the public, media, and politicians of all stripes. But one reason for high prices has flown under the radar. When drug companies reformulate their product...

Published Thu, Jun 01 2017 8:02 AM by Health Affairs BlogHealth Affairs Blog

Filed under: Costs and Spending, antitrust, Hatch-Waxman Act, Drugs and Medical Innovation, prescription drug prices, product hopping, drug reformulations

Syndication

Recent Posts

Tags

Archives